Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation

Fig. 1

Common samples, biomarkers, and clinical applications in liquid biopsy for pancreatic cancer. Blood is typically the most commonly used material in liquid biopsy, in addition to pancreatic juice, saliva, urine, and stool. Circulating tumour cells, circulating tumour DNA, noncoding RNAs, and extracellular vesicles are among the most common biomarkers. Liquid biopsy has a wide range of clinical applications, playing a crucial role in early diagnosis, treatment monitoring, and prognosis evaluation. Created with BioRender.com

Back to article page